Download Citation
Article Source:
The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy
Nagaoki Y,
Imamura M,
Aikata H,
Daijo K,
Teraoka Y,
et al.
(2017)
The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.
PLOS ONE 12(8): e0182710.
https://doi.org/10.1371/journal.pone.0182710